CMF
CLB icon

Counterpoint Mutual Funds’s Core Laboratories CLB Stock Holding History

Counterpoint Mutual Funds’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,385
Closed -$119K – 325
2023
Q1 		$119K Buy
+5,385
New +$126K 0.1% 54

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Counterpoint Mutual Funds's CLB Position: Q2 2023 in Review

Counterpoint Mutual Funds sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 5,385 shares — an estimated $119K sold.

Counterpoint Mutual Funds first reported a position in CLB in Q1 2023 and held it in 1 quarter. The position peaked at $119K in Q1 2023. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Counterpoint Mutual Funds reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 5,385 Core Laboratories shares in Q2 2023, an estimated $119K.
  • Counterpoint Mutual Funds first reported a position in Core Laboratories in Q1 2023 and held it in 1 quarter.
  • Counterpoint Mutual Funds's Core Laboratories position peaked at $119K in Q1 2023.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2023, filed 13 Jul 2023.